Skip to content

Eurosupport 6: Testing the effectiveness of a computer-assisted counselling intervention on safer sex (CISS) for people living with HIV (PLHIV)

Eurosupport 6: Testing the effectiveness of a computer-assisted counselling intervention on safer sex (CISS) for people living with HIV (PLHIV) - CISS for people living with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34668
Enrollment
80
Registered
2010-04-20
Start date
2011-05-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

human immuno-deficiency virus infection

Interventions

The CISS is to be provided as a CD-rom to all Eurosupport6 participating centres. It will provide the guided focus of the counselling intervention. The role of the counsellor will be to support the

Sponsors

Institute of Tropical Medicine
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Being over 18 years of age; -Having received their HIV-diagnosis a minimum of 6 months ago; -Migrant status (man or woman) or man who has sex with other men (MSM) -Understand the study goal, purpose and procedures involved; -Having given their informed consent.

Exclusion criteria

Exclusion criteria: -Being under 18 years of age; -Having received their HIV diagnosis less than 6 months ago; -No migrantstatus or MSM -A language barrier prevents counselling possibility; -Not understanding the study*s purpose and procedures and therefore unable to give informed consent.

Design outcomes

Primary

MeasureTime frame
Over the whole study period, data are collected on the primary and secondary outcomes. Data are collected using a computerised system, i.e. study participants fill out the questionnaire on a PC provided at the clinic, using Snap®-software. Data assessments occur at 5 points in time: screening, baseline assessment, post-intervention assessment, and at 3- and 9-months after completion of the intervention. Note that not all study variables are assessed at each assessment: overview of study variables and the moments of assessment are given in annex 5.

Secondary

MeasureTime frame
Seen Annex 5 of the study protocol

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)